Gastric Cancer Foundation tumor Archives | Page 2 of 3

ASCO: In stomach cancer, AstraZeneca and Daiichi’s Enhertu goes where Roche’s Kadcyla couldn’t

Jun 01 2020

In a pivotal study, patients taking Enhertu from AstraZeneca and Daiichi Sankyo saw their tumors shrink and were still alive after a...

Combined therapy may improve clinical responses for endometrial, colorectal and gastric tumors

Apr 15 2020

A study by MD Anderson found that tumors with DNA mismatch repair, including gastric cancer, responded to a combo of an investigational...

Immunotherapy with Anti-PD-1 Effective for Patients with Solid Tumors

Feb 20 2020

A review of 13 clinical trials published in JAMA Oncology found that patients with solid tumors, including stomach tumors, had better survival...

Blueprint Medicines Announces FDA Approval of AYVAKIT™ (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA Exon 18 Mutant Gastrointestinal Stromal Tumor

Feb 05 2020

Blueprint Medicines won FDA approval for Ayvakit (avapritinib), the first treatment for gastrointestinal stromal tumors (GISTs) that targets platelet-derived growth factor alpha...

Cancer’s Addiction Could Be A Way to Defeat It

Jan 24 2020

Researchers at the University of Melbourne created gastric cancer “organoids,” tiny replicas of diseased tissue, and used them to discover that a...

Novel, high-accuracy blood test can screen for multiple cancers

Dec 24 2019

An investigational blood test for cancer was able to identify early-stage tumors, including gastric cancer, with high accuracy, according to research presented...